Showing 3881-3890 of 4956 results for "".
- Almirall on the Move with Three New Collabshttps://practicaldermatology.com/news/almirall-on-the-move-with-three-new-collabs/2460248/With three new strategic agreements, Almirall, S.A. is set to strengthen their early-stage research portfolio and expand their pipeline in medical dermatology. Alimirall and 23andMe have signed an agreement allowing Almirall to in-license 23
- It’s Gold and Silver for Sebacia with Sienna Acquisitionhttps://practicaldermatology.com/news/its-gold-and-silver-for-sebacia-with-sienna-acquisition/2460247/Mr. Chuck Abraham is the new Chief Executive Officer of Sebacia, Inc. Sebacia is preparing a targeted commercial launch of Sebacia Microparticles in the US for treatment of acne early in 2020 with plans to expand to additional territories later in th
- The HydraFacial Company Takes on Scalp Healthhttps://practicaldermatology.com/news/the-hydrafacial-company-takes-on-scalp-health/2460245/The HydraFacial Company is launching
- Ortho Dermatologics Expands Solta Medical Team with New Hireshttps://practicaldermatology.com/news/ortho-dermatologics-expands-solta-medical-team-with-new-hires/2460237/Ortho Dermatologics is staffing up its Solta Medical business unit. The new appointments include the following: Liz Newman, General Manager, Solta, North America Newman first joined Solta in January 2018 as se
- Castle Creek Completes Acquisition of Fibrocell Sciencehttps://practicaldermatology.com/news/castle-creek-completes-acquisition-of-fibrocell-science/2460235/Castle Creek Pharmaceutical Holdings, Inc. completed the acquisition of Fibrocell Science, Inc. Both companies have advanced investigational therapies for the treatment of epidermolysis bullosa (EB) into late-stage clinical research. Prior to the acquisition, Fibrocell initiated a pivot
- Daavlin, HealthLens Partner to Increase Phototherapy Accesshttps://practicaldermatology.com/news/daavlin-healthlens-partner-to-increase-phototherapy-access/2460232/Daavlin, a leading U.S. manufacturer of phototherapy units, is teaming up with HealthLens to increase access to phototherapy via teledermatology. Appointment wait times for dermatology services have increased by 46 percent since 2009, according to
- Proscia and Johns Hopkins School of Medicine Collaborate to Bring AI Applications to High-Impact Diseases and Specialties in Pathologyhttps://practicaldermatology.com/news/proscia-and-johns-hopkins-school-of-medicine-collaborate-to-bring-ai-applications-to-high-impact-diseases-and-specialties-in-pathology/2460231/Proscia, a provider of AI-enabled digital pathology software, and Johns Hopkins School of Medicine, one of the leading academic medical centers in the US, will collaborate on the development of computational applications that incorporate artificial intelligence (AI) to advance the practice of pat
- Cutera Rolls Out Heroes Among Us Programhttps://practicaldermatology.com/news/cutera-rolls-out-heroes-among-us-program/2460228/Cutera is launching its new “Heroes Among Us” program to showcase patients who’ve been positively affected by Cutera technologies. The new program was launched at the Cutera University Clinical Forum (CUCF) in Scott
- Norfolk Dermatologist Recognized for Increasing Accessibility for Patientshttps://practicaldermatology.com/news/norfolk-dermatologist-recognized-for-increasing-accessibility-for-patients/2460227/Dermatologist Abby Van Voorhees, MD, FAAD, is an American Academy of Dermatology Patient Care Hero for her leadership at the Rapid Access Clinic at the Eastern Virginia Medical School Dermatology Practice in Norfolk, Va. The Eastern Virginia Medical School Dermatology practice allo
- CBD Brands Initiates AD studyhttps://practicaldermatology.com/news/cbd-brands-initiates-ad-study-1/2460226/In the wake of the US Food and Drug Administration’s (FDA) recent revised warning about the risks of CBD products, CBD Brands is initiating a study to investigate a novel cannabidiol lotion for the treatment of atopic dermatitis (AD). The study aims to provide a preliminary assess